Mannose-binding lectin (MBL) in health and disease.
Mannose-binding lectin (MBL) is the most intensively studied human collectin. It is recognized to be a versatile macro-molecule with many of the functional characteristics of IgM, IgG and Clq. In the presence of calcium the protein can bind to a wide spectrum of oligosaccharides through multiple lectin domains. Such binding to the repeating sugar arrays on microbial surfaces may result in direct uptake by one or more collectin receptors on phagocyte surface or may trigger the activation of a pro-serine protease complex (MASP 1 and MASP 2) leading to cleavage of C4 and C2 of the classical complement pathway. Although serum levels of MBL are normally rather low (1500 micrograms/litre) there is increasing evidence that the protein plays an important role in immune defence, particularly during the phase of primary contact with a microorganism. This is suggested by the observed association of an increased incidence of infections in individuals with structural mutations in exon 1 of the MBL gene. A cluster of such mutations in codons 52, 54 and 57 lead to secondary structural abnormalities of the collagenous triple helix and a failure to form biologically functional higher order oligomers. The codon 54 mutation has been identified in several Eurasian populations whereas the codon 57 mutation is characteristic of sub-Saharan populations. One intriguing paradox arising from the MBL genotyping studies is the observation that in many populations there are surprisingly high frequencies of either the codon 54 or codon 57 mutation, suggesting that there may be some biological advantage associated with absence of the protein. Nevertheless, various groups have reported either low serum levels of MBL or an increased frequency of the structural gene mutations in patients with suspected immunodeficiencies, those with frequent unexplained infections and those with systemic lupus erythematosus. There is also evidence that the rate of progression of AIDS in HIV positive men is faster in those with such mutations. A recently published study of a consecutive series of admissions to a paediatric unit suggests that children presenting with an infectious aetiology are significantly more likely to have a MBL mutation. Moreover, this association was independent of age. Prospective studies are underway to address the questions raised by these findings.
Turner
M W
MW
Immunobiology Unit, Institute of Child Health, London, UK. m.turner@ich.ucl.ac.uk
D000026:Abortion, Habitual / Q000235:genetics / Q000276:immunology; D000328:Adult; D001327:Autoimmune Diseases / Q000235:genetics / Q000276:immunology; D001419:Bacteria / Q000276:immunology; D002118:Calcium / Q000378:metabolism; D002352:Carrier Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D002648:Child; D003062:Codon / Q000235:genetics; D015331:Cohort Studies; D037222:Collectins; D018450:Disease Progression; D004198:Disease Susceptibility; D005006:Ethnicity / Q000235:genetics; D005260:Female; D005658:Fungi / Q000276:immunology; D020022:Genetic Predisposition to Disease; D015658:HIV Infections / Q000235:genetics / Q000276:immunology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000235:genetics; D007239:Infections / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000235:genetics / Q000276:immunology; D008297:Male; D009844:Oligosaccharides / Q000378:metabolism; D009895:Opsonin Proteins / Q000276:immunology; D017354:Point Mutation; D011247:Pregnancy; D011446:Prospective Studies; D011485:Protein Binding; D013329:Structure-Activity Relationship
D002352:Carrier Proteins; D003062:Codon; D037222:Collectins; D009844:Oligosaccharides; D009895:Opsonin Proteins; D002118:Calcium